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Abstract Ewing Sarcoma of the head and neck region is an ex-
tremely rare entity. Treatment usually involves surgery, 
chemotherapy and radiotherapy in varying sequences. 
We present the third case to date of Ewing sarcoma 
of the larynx in a paediatric population. A 5-year-old 
boy presented to emergency room with acute respira-
tory distress. Computerized tomography scan showed 
a mass in the supraglottis; he was intubated using vid-
eolaryngoscope and tracheostomy was avoided, mass 
was removed by cold dissection. Final histopathologic 
examination revealed Ewing sarcoma. Further workup 
showed no systemic metastasis. Patient was advised 
adjuvant therapy which the family refused. Currently 
he is doing fine on 2 years of follow-up.
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Introduction
Children presenting to pediatric emergency with 
stridor is not uncommon. Most common causes of 
stridor in pediatric population are laryngomalacia, 
subglottic stenosis or vocal cord paralysis (1). We 
report the case of a 5-year-old boy who presented 
with stridor to the emergency room and was found 
to have a laryngeal mass that was excised and diag-
nosed as Ewing sarcoma. The clinical presentation, 
management and outcome has been discussed with 
a review of the literature. Only two pediatric cases 
of Ewing sarcoma have been previously reported 
more than two to three decades ago (2). Overall, a 
total of seven cases with Ewing sarcoma have been 
reported to occur in the larynx.
Case Presentation
A 5-year-old boy presented to the emergency de-
partment with progressive change in his voice for 
eight months, difficulty in breathing for six months 
and stridor for three days. He had no difficulty in 
swallowing. The mother of the child also denied 
any history of foreign body ingestion, intubation, 
trauma or fever. On examination, the child was 
anxious, restless and in moderate respiratory dis-
tress. Nebulization with epinephrine and steroid 
injection improved the condition of the child with 
reduced work of breathing and resulted in a better 
respiratory rate. The child was then moved for a 
computerized tomography (CT) scan that showed 
a rounded soft tissue density mass of 18x16 mm 
in the supraglottic region and the ventricles, it was 
abutting the epiglottis, likely representing papillo-
ma (Figure 1).
The child was moved to the operating room. He 
was examined with the help of a videolaryngo-
scope, and a mass of about 2x2 cm was seen to 
obstruct the upper airway (Figure 2). He was 
intubated and tracheotomy was avoided. The tu-
mor was firm in consistency and was excised in 
piecemeal with cold knife technique (Figure 3). 
The patient was extubated uneventfully, with no 
stridor or dyspnea. He was observed for 24 hours 
and discharged in stable condition on the second 
post-operative day. Histopathological examina-
tion revealed squamous mucosa covered frag-
ments showing infiltration by a neoplastic lesion 
arranged in diffuse sheets. The tumor cells were 
uniform, round, and exhibited hyperchromatic nu-
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clei with scant eosinophilic cytoplasm (Figures 4 a-d). Increased 
mitotic figures were seen. Histologically, differential diagnoses 
of embryonal rhabdomyosarcoma, acute lymphoblastic lympho-
ma/leukemia and Ewing sarcoma were considered. A Periodic 
acid-Schiff (PAS) stain highlighted abundant cytoplasmic gly-
cogen granules (Figure 5a). Immunohistochemical staining with 
CD99 was strongly membranous positive (Figure 5b) and cyclin 
D1 showed strong nuclear positivity. Desmin, leukocyte com-
mon antigen (LCA) and terminal deoxynucleotidyl transferase 
(TdT) were negative, thus ruling out rhabdomyosarcoma and 
acute lymphoblastic lymphoma, respectively. Cytokeratin AE1/
AE3 and p63 were negative, ruling out an undifferentiated car-
cinoma. CD117 was performed to rule out myeloid sarcoma 
and was negative. Histological features favored Ewing sarcoma. 
Fluorescence in situ hybridization (FISH) for Ewing sarcoma 
break apart (EWSR1) probe was performed and revealed nu-
clei in which one pair of the probe signals was split apart due 
to a rearrangement in the EWSR1 gene (green arrows, Figure 
6). The FISH result confirmed the diagnosis of Ewing sarcoma. 
For further management, the patient was referred to paediatric 
oncology. His metastatic workup was done with bone scan and 
bone marrow biopsy. The results were negative with no evidence 
of spread of the disease. The patient was advised adjuvant che-
motherapy with radiation, but the parents refused. He is under 
regular follow-up and at two years of follow-up has shown no 
symptoms or signs of recurrence. Informed consent was taken 
from the father to report this case.
Discussion
Ewing sarcoma is the second most frequent primary bone malig-
nancy after osteosarcoma, mostly occurring in the flat bones of 
the axial skeleton and in the long bones. It has been divided into 
classic Ewing sarcoma of the bone, extraskeletal Ewing sarcoma 
(EES), and malignant peripheral primitive neuroectodermal tu-
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Figure 3. Adequate airway post excision of the laryngeal mass
Figure 2. Video laryngoscopy showing laryngeal mass
Figure 1. CT scan (coronal and sagittal views) showing mass in 
supraglottis
Figure 4. a-d. Low and high power examination of laryngeal Ewing 
sarcoma. Arrow in Figure a shows overlying stratified squamous 
epithelial lining. The tumor is arranged in diffuse sheets and has 





Figure 5. a, b. Abundant cytoplasmic granules are seen on PAS stain 
(a) and tumors cells showed strong membranous staining for CD99 
immunohistochemical stain (b)
a b
mor (pNET) (8). The debate on the exact cell of origin of Ewing 
sarcomas is yet unresolved. Histological features suggest a poorly 
differentiated tumor having both mesenchymal and neuroecto-
dermal features. Head and neck Ewing sarcoma represents less 
than 9% of all Ewing sarcomas, with mandibular tumors being 
the most common (9). In a recent 43-year review from the Mayo 
Clinic only 17 patients had Ewing sarcoma in the head and neck 
region; of these most were found in bony structures, namely in the 
cervical spine and the skull (10). Majority of their patients were 
treated with surgery with or without adjuvant chemoradiation in 
varying sequences. They reported no case arising primarily in the 
larynx. Majority of the patients were adults and only one patient 
was under five years of age. Ellis et al. (11) used the Surveillance, 
Epidemiology, and End Results (SEER) database to publish the 
largest series of Ewing sarcoma in the head and neck. They found 
Ewing sarcomas in the head and neck to be smaller, with lower 
rates of metastasis at presentation when compared to those orig-
inating at other sites; but did not deem it to be a separate clinical 
entity, and the prognosis of Ewing sarcoma in the head and neck 
was not different than that at other primary sites. The presence 
or absence of metastasis is a key prognostic factor for Ewing sar-
coma. In the head and neck Ewing sarcomas, the frequency of 
metastasis at presentation is lower, although larger tumor volumes 
are associated with worse survival rates (12-14). 
The youngest pediatric patient of laryngeal Ewing sarcoma was 
a 1-day-old male baby who presented with respiratory distress 
and stridor at the time of birth. Laryngoscopy and bronchosco-
py showed a right sided solitary mass causing obstruction of the 
glottis. A biopsy was taken for frozen section which revealed an 
undifferentiated malignant tumor. His metastatic workup was 
negative. A tracheostomy was performed as the tumor was ob-
structing the airway. A total laryngectomy was performed on the 
10th day of life. Final diagnosis was a malignant undifferentiated 
sarcoma consistent with an extraskeletal Ewing sarcoma. Patient 
was alive and free of disease 2 years after the surgery (1). The 
second pediatric case was a 9-month-old male baby. A laryngec-
tomy was done and patient received chemotherapy as well. The 
tumor recurred locally (2).
The other five cases of laryngeal Ewing sarcoma occurred in 
adults with age ranging from 33 to 74 years (mean 54.6 years; 
median 53 years) (3-7). Three were male and two were female. 
Yang and Hong (3) reported laryngeal Ewing sarcoma in a 
74-year-old male. The patient presented with acute respiratory
distress; after emergency tracheostomy, workup revealed Ewing
sarcoma. He underwent laryngectomy, neck dissection and ad-
juvant radiation. The patient stayed disease-free for six months. 
Another 68-year-old male was reported with a 3-month his-
tory of hoarseness and aphonia. He had neoplastic infiltration 
occupying the anterior commissure, both vocal cords and the 
laryngeal ventricles. The patient refused laryngectomy and un-
derwent induction chemotherapy followed by radiation. Com-
plete regression of the tumor was seen and patient did well at 30 
months follow-up (4). 
The current treatment line for Ewing sarcoma includes six cy-
cles of neoadjuvant chemotherapy, followed by local therapy, i.e., 
surgery, radiotherapy or both, with continued chemotherapy for 
a year. The initial evaluation before treatment should include im-
aging which can assess the degree of compromised bone cortex 
and its relation to adjacent anatomic landmarks. Magnetic reso-
nance imaging remains the gold standard for radiographic char-
acterization of Ewing sarcoma as it can determine the relation-
ship of the tumor with the adjacent structures. Patients should 
also receive chest CT and technetium Tc 99m bone scanning or 
PET scanning in order to identify metastatic lesions. 
Conclusion
Ewing sarcoma of the larynx is a rare entity especially in the 
paediatric age group. The diagnostic challenge lies in differen-
tiating this tumor from other causes of round blue cell tumors. 
Extensive immunostaining and FISH confirm the diagnosis. 
Treatment protocols are not uniform owing to the rare occur-
rence. Our patient was managed by surgery alone and no recur-
rence was seen on two years follow-up. 
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Figure 6. LSI EWSR1 Dual Color, Break Apart Rearrangement 
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